Aug 5, 2024 07:02AM
Aug 5, 2024 07:00AM
May 7, 2024 04:05PM
May 7, 2024 04:05PM
Apr 24, 2024 09:27PM
Apr 24, 2024 09:20PM
Apr 24, 2024 09:19PM Invitae Enters into Agreement with Labcorp for Sale of Business
Mar 6, 2024 07:15AM
Nov 8, 2023 04:01PM
Aug 8, 2023 04:01PM
May 9, 2023 04:01PM
Feb 28, 2023 04:10PM
Dec 20, 2022 07:32AM
Dec 20, 2022 07:30AM Integrated DNA Technologies Acquires ArcherDX Next Generation Sequencing Research Assays from Invitae Corporation
Nov 8, 2022 04:05PM
Aug 9, 2022 04:05PM
May 3, 2022 04:05PM
Feb 24, 2022 04:05PM
Nov 8, 2021 04:05PM
Sep 7, 2021 07:02AM
Sep 7, 2021 07:00AM Invitae to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to Improve Personal Outcomes and Global Research
Aug 9, 2021 07:08AM
Aug 3, 2021 04:05PM
Jul 20, 2021 07:05AM
Jul 20, 2021 07:02AM
Jul 20, 2021 07:02AM
Jul 7, 2021 07:00AM
May 4, 2021 04:05PM Invitae Reports $103.6 Million in Revenue Driven by 259,000 in Billable Volume in First Quarter of 2021
Apr 5, 2021 09:25AM
Apr 5, 2021 07:30AM
Apr 5, 2021 07:30AM
Feb 17, 2021 04:05PM
Jan 22, 2021 05:57AM
Jan 21, 2021 08:37PM
Jan 20, 2021 04:06PM InVitae (NVTA) Announces Proposed $400M Share Common Offering
Jan 20, 2021 04:05PM
Jan 11, 2021 07:36AM
Jan 11, 2021 07:30AM
Dec 17, 2020 07:30AM
Nov 5, 2020 04:05PM
Oct 5, 2020 07:30AM
Aug 26, 2020 08:00AM Civilization Ventures Announces $35M Second Fund
Aug 5, 2020 09:28AM
Aug 4, 2020 04:05PM
Jul 6, 2020 05:15PM
Jul 2, 2020 11:10AM
Jun 26, 2020 06:18AM
Jun 22, 2020 07:11AM
Jun 22, 2020 07:00AM Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
May 5, 2020 04:05PM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All